TKTrille Kristina Kjaer

Trille Kristina Kjaer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Trille Kristina Kjaer has a total of 172 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Persistent Health Disparities Among Adult Cancer Survivors

    by Trille K. Kjaer, Anne K. G. Levinsen, Mia K. Grand, Erik Jakobsen, Michael Borre, Robert Zachariae, Peer Christiansen, Peter Christensen, Lisbet R. Hölmich, Peter de Nully Brown, et al.

    Cancer survivors face elevated risks of age‐ and treatment‐related health conditions, possibly due to accelerated biological aging from cancer therapy. The role of social determinants of health (SDOH) in these aging trajectories remains understudied. We conducted a retrospective cohort study of 109,224 curatively treated Danish cancer survivors (lung, breast, prostate, or colon cancer, diagnosed between 1997 and 2018) and 574,022 age‐ and sex‐matched cancer‐free individuals. SDOH was assessed using educational level and cohabitation status. Using national registries, we investigated associations between SDOH and 16 post‐cancer new morbidities with Cox proportional hazard models and flexible parametric models. During a median 6.9‐year follow‐up, cancer survivors had significantly higher rates of new morbidities than cancer‐free individuals. Lung cancer survivors had elevated hazard rates for 14 morbidities, breast cancer survivors had increased rates for 12 morbidities, prostate cancer survivors exhibited elevated rates for 8 morbidities, and colon cancer survivors had rates for 14 morbidities. Educational disparities were evident: survivors with short education had higher rates for chronic respiratory disease (HRs: 1.30–1.55 across cancer types), heart failure (HRs: 1.50–1.54 in breast and colon), diabetes (HRs: 1.67–1.95 in breast, prostate, and colon), and depression (HRs: 1.32–1.37 in breast and colon). Living alone was also associated with increased but less pronounced rates. Cancer survivors experience elevated rates for age‐ and treatment‐related post‐cancer new morbidities compared to cancer‐free individuals. Sociodemographic disadvantages, particularly short education, further increase these rates. These findings suggest that SDOH play an important role in post‐cancer aging, highlighting the need for targeted interventions addressing social determinants in survivorship care.

  • Open Access

    International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100

    by Louis Fox, Marieke van Leeuwen, Jennifer M. Jones, Amal Al-Omari, Haneen Abaza, Muna Al-Khaifi, Martin Eichler, Sue Hartup, Galina Velikova, Nanna Friðriksdóttir, et al.


  • Prevalence of concurrent severe self-reported late symptoms and functional limitations in cancer survivors: a cross-sectional study of sociodemographic, clinical, and lifestyle associations

    by Trille Kristina Kjaer, Anne Katrine Graudal Levinsen, Erik Jakobsen, Ismail Gögenur, Michael Borre, Peer Christiansen, Robert Zachariae, Peter Christensen, Peter de Nully Brown, Lisbet Rosenkrantz Hölmich, et al.

    This population-based study investigated the prevalence of concurrent severe symptoms and functional limitations among Danish cancer survivors, examining associations with sociodemographic, clinical, and lifestyle factors. We conducted a cross-sectional analysis using data from the nationwide SEQUEL questionnaire study (2022), including 40,766 survivors 2- to 12-year post-diagnosis (2010-2019). Up to 21 symptoms, five functioning domains, and sexual satisfaction were assessed using validated instruments (EORTC QLQ-C30, EORTC Item Library, QLQ-SHQ22, GAD-7, PHQ-9). Data were obtained from Danish registries, clinical databases, and self-report. Symptoms and functional limitations were categorized as severe using predefined thresholds. Ordinal logistic regression models examined factors associated with concurrent symptoms. Mean symptom count was 4.1 for women (range 0-21, SD 3.19) and 3.3 for men (range 0-20, SD 2.72), with 25% of women and 16% of men experiencing ≥ 5 concurrent severe symptoms. Lung cancer survivors reported the highest symptom burden. Factors significantly associated with concurrent symptoms included short education, lower income, living alone, multiple comorbidities (CCI ≥ 2), advanced disease, palliative treatment, current smoking, and higher BMI, with ORs ranging from 1.29-2.19 (women) and 1.23-2.25 (men). Impaired functioning showed similar associations. Concurrent late symptoms are common among cancer survivors, indicating complex health issues varying by cancer type and clinical characteristics, with clear socioeconomic disparities and lifestyle associations. These findings highlight subgroups who may benefit from interventions targeting multiple symptoms and underscore the importance of addressing social determinants and lifestyle factors in survivorship care.


  • The mediating role of new morbidities on social inequality in mortality after curative cancer treatment – a SEQUEL study

    by Trille Kristina Kjaer, Mia Klinten Grand, Anne Katrine Graudal Levinsen, Erik Jakobsen, Michael Borre, Robert Zachariae, Peer Christiansen, Søren Laurberg, Peter Christensen, Lisbet Rosenkrantz Hölmich, et al.

    Background Socioeconomic factors are linked to cancer survival. While cancer stage and treatment mediate this association, the role of new morbidities after cancer treatment is less understood. We investigated educational disparities in cancer mortality and whether it is explained by differences in death from new morbidities. Methods 85,849 cancer survivors with lung, breast, prostate, colorectal cancers were included. Follow-up for overall and cause-specific death began one year after diagnosis, lasting up to 16 years. Cox proportional hazard models estimated the association between education and death. Mediation analyses explored whether new morbidities mediated this association. Results Survivors with short education had higher mortality, particularly after breast and colon cancers, with a significant proportion of deaths due to new morbidities (breast cancer e.g. new primary cancers (HR 1.59, 95% CI:1.35,1.87), kidney and urinary problems (HR 4.16, 95% CI:1.24,13.97), and chronic respiratory issues (HR 2.99, 95% CI:1.86–4.79). Similar trends were observed in colon cancer survivors e.g. ischemic heart disease (HR 1.70, 95% CI:1.13,2.56) and heart failure (HR 3.53, 95% CI:1.35,9.19). Although some new morbidities were statistically significant mediators, they accounted for only a small proportion of the effects. Conclusions Educational disparities persist in cancer survivorship, with new morbidities contributing to higher mortality rates among survivors with shorter education.


  • Uncovering causal clues in the development of second primary cancers – Authors' reply

    by Trille Kristina Kjaer, Christoffer Johansen, Susanne Oksbjerg Dalton

  • Cumulative incidence of second primary cancers in a large nationwide cohort of Danish cancer survivors: a population-based retrospective cohort study

    by Trille Kristina Kjaer, Elisabeth Anne Wreford Andersen, Giske Ursin, Signe Benzon Larsen, Pernille Envold Bidstrup, Jeanette Falck Winther, Michael Borre, Christoffer Johansen, Susanne Oksbjerg Dalton


  • Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA

    by Maja Halgren Olsen, Thomas Maltesen, Pernille Lassen, Trille Kristina Kjaer, Jørgen Johansen, Hanne Primdahl, Elo Andersen, Claus Andrup Kristensen, Maria Andersen, Mohammad Farhadi, et al.

    The socioeconomic differences in survival are pronounced for patients diagnosed with head and neck cancer; disease stage at diagnosis is suggested to be a main driver of this association. This nationwide, population-based study investigates socioeconomic differences in the pre-diagnostic interval and disease stage at diagnosis. Information on patient-reported symptoms, symptom onset and disease-specific factors was obtained from the nationwide population-based Danish Head and Neck Cancer Group (DAHANCA) database for patients diagnosed with head and neck squamous cell carcinoma between 2008 and 2019 in Denmark. Socioeconomic position (SEP) was measured by individual-level education, income and cohabitation status obtained from administrative registers. Socioeconomic differences in the interval from symptom onset to diagnosis were investigated in general linear models with 95% confidence intervals (CIs); overall and by subsite, symptom and comorbidity score. Consultation patterns prior to diagnosis were examined using methods for change-point detection. Associations with advanced-stage disease were estimated in logistic regression models. Patients with low, medium and high SEP had a similar interval from patient-reported symptom onset to diagnosis of 10 weeks. Although this interval varied according to primary symptom and anatomical subsite, no apparent socioeconomic differences were observed within these subgroups. Aligned with the patient-reported symptom onset, a distinct increase in consultation rates was observed at 9 weeks (95% CI [7.3; 10.7]) for patients with low SEP and 7 weeks (95% CI [4.8; 9.2]) for patients with high SEP, with overlapping CIs. Patients with low compared to high SEP had increased odds for advanced-stage glottic and oral cavity squamous cell carcinoma. For the remaining subsites the association varied according to SEP-indicator and TNM-edition. The interval from symptom onset to diagnosis and consultation patterns were similar across SEP groups. Still, socioeconomic differences in stage at diagnosis were observed for some - but not all - subsites.


  • Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease

    by Thea Helene Degett, Ida Rask Moustsen-Helms, Signe Benzon Larsen, Trille Kristina Kjær, Anne Tjønneland, Susanne Krüger Kjær, Christoffer Johansen, Ismail Gögenur, Susanne Oksbjerg Dalton

    The risk of cardiovascular events in patients treated for colorectal cancer is debated due to diverging results in previous studies. Colorectal cancer and cardiovascular disease share several risk factors such as physical inactivity, obesity, and smoking. Information about confounding covariates and follow-up time are therefore essential to address the issue. This study aims to investigate the risk of new-onset cardiovascular events for patients with stage I-III colorectal cancer receiving elective surgery compared to a matched population. Using a prospective cohort, we compared cardiovascular events among 876 patients treated with elective surgery for incident stage I-III colorectal cancer diagnosed between January 1st, 2001 and December 31st, 2016 to a cancer-free cohort matched by age, sex, and time since enrollment (N = 3504). Regression analyses were adjusted for lifestyle, cardiovascular risk factors, and comorbidity. Multivariable analyses were used to identify risk factors associated with cardiovascular events in the postoperative (90 days after elective surgery). After a median follow-up of 3.9 years, the hazard ratio (HR) for incident heart failure was 1.53 (95% CI 1.02-2.28) among patients operated for colorectal cancer. The postoperative risk of myocardial infarction or angina pectoris was associated with the use of lipid-lowering drugs. Long-term risks of cardiovascular events were ASA-score of III+IV and lipid-lowering drugs with HRs ranging from 2.20 to 15.8. Further, the use of antihypertensive drugs was associated with an HR of 2.09 (95% CI 1.06-4.13) for angina pectoris or acute myocardial infarction. Heart failure was associated with being overweight, diabetes, and anastomosis leakage. We observed an increased hazard of heart failure in patients operated on for stage I-III colorectal cancer compared to cancer-free comparisons. We identified several potential risk factors for cardiovascular events within and beyond 90 days of elective surgery.


  • Association between anxiety and depression symptoms and completion of first-line treatment in newly diagnosed lung cancer patients

    by Josephine Maffait Hansen, Trille Kristina Kjaer, Anders Mellemgård, Marianne Stensøe Oksen, Ingelise Andersen, Susanne Oksbjerg Dalton

    Poor adherence to cancer treatment is commonly seen [1–3] with consequences including worse overall survival and quality of life [2]. In line with this, almost half (46%) of lung cancer patients di...


  • Open Access

    Association between Health-Related Quality of Life and Completion of First-Line Treatment among Lung Cancer Patients

    by Anne Katrine G. Levinsen, Susanne O. Dalton, Ingelise Andersen, Anders Mellemgaard, Marianne S. Oksen, Lena Saltbæk, Nina H. G. Hansen, Signe Carlsen, Trille K. Kjaer

    Experts recommend assessing lung cancer patients’ health-related quality of life (HRQOL) in the diagnostic evaluation. We investigated the association between HRQOL and completion of first-line treatment among lung cancer patients in a prospective cohort study. Clinical information on lung cancer patients was obtained from medical records, and information on quality of life and lung cancer-related symptoms was obtained through questionnaires at time of diagnosis. We used directed acyclic graphs to identify potential confounders and mediators between HRQOL and completion of first-line treatment. The association between functioning levels and symptoms and completion of first-line oncological treatment was estimated as odds ratios, with 95% confidence intervals, in logistic regression models. In all, 137 patients (52% men, mean age: 69 years) participated, out of 216 invited. Patients who reported reduced functioning had significantly increased ORs for not completing first-line treatment: poor physical function (OR 4.44), role function (OR 6.09), emotional function (OR 5.86), and social function (OR 3.13). Patients with fatigue (OR 7.55), pain (OR 6.07), appetite loss (OR 4.66), and financial difficulties (OR 17.23) had significantly increased ORs for not completing the first-line treatment. Reduced functioning and presence of symptoms were associated with not completing first-line treatment. An assessment of HRQOL could potentially aid the diagnostic evaluation and treatment planning for lung cancer patients.